Guru Ownership Trend
Guru Analysis for Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $19.45 M.
Top institutional holders include Steven Cohen and Paul Tudor Jones.
Institutional sentiment is currently Bullish. This is evidenced by a $2.01 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 20.2%. Conversely, Paul Tudor Jones reduced exposure by 62.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Janux Therapeutics, Inc. (JANX)
Major holders include Steven Cohen ($16.07 M), Paul Tudor Jones ($412,677). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.19 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.01 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited JANX. The total reported sell value was $687,618.93.
Yes, 0 managers opened new positions in JANX, and 1 increased their existing holdings. The total reported buy value was $2.7 M.